SECOND GENERATION MONOCLONAL ANTIBODIES HAVING BINDING SPECIFICITY TO TAG-72 AND HUMAN CARCINOMAS AND METHODS FOR EMPLOYING THE SAME

摘要

The present invention relates to second generation monoclonal antibodies having binding specificity to a tumor associated glycoprotein having an approximate molecular weight of >106d (''TAG-72'') and human carcinomas and methods for employing the same. Hybridomas producing such antibodies have been prepared.